- Home
- » Tags
- » Dactinomycin
Top View
- 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
- Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children’S Cancer Study Group Study Gareth J
- BC Cancer Protocol Summary for Adjuvant Therapy for Rhabdomyosarcoma Using Vincristine, Dactinomycin, and Cyclophosphamide
- GOTDMR Protocol
- VACA (Vincristine Dactinomycin Doxorubicin Cyclophosphamide)
- Chemotherapy Extravasation Management
- 2019 Table of Drugs
- Types of DRUGS ACTING on DNA (In Chapter 9) Intercalating Agents
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- How to Order Chemotherapy at Shands at the University of Florida - Inpatient
- Vincristine, Dactinomycin, Cyclophosphamide
- COSMEGEN (Dactinomycin) MB1904
- Dactinomycin-D Richard J. Cardosi, MD, FACOG
- Management of Gestational Trophoblastic Neoplasia Ansar Hussain*, Shiekh Aejaz Aziz, Gul Mohd
- Management of Extravasation of a Systemic Anti-Cancer Therapy Including Cytotoxic Agents
- Handling Cytostatic Drugs: Contents
- Update in Cancer Chemotherapy: Genitourinary Tract Cancer, Part 4: Testicular Cancer
- Dactinomycin Induces Complete Remission Associated with Nucleolar Stress Response in Relapsed/Refractory NPM1-Mutated AML
- Single-Agent Therapy for Low Risk Gestational Trophoblastic Neoplasia
- Chemotherapy Protocol
- Inhibition of Transcription by Dactinomycin Reveals a New Characteristic of Immunogenic Cell Stress Juliette Humeau
- Whole Lung Irradiation in Patients with Osteosarcoma and Ewing Sarcoma
- COSMEGEN® for INJECTION (Dactinomycin for Injection) (Actinomycin D)
- Acute Mucositis and Gastrointestinal Toxicity Caused by Radiotherapy Or Systemic Anti-Cancer Treatment 2019
- Cosmegen Powder for Injection Because This Will Result in the Formation of a Precipitate
- Shortages and Price Variability of Essential Cytotoxic Medicines for Treating Children with Cancers
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- DRUG NAME Toxicities: Acute: Delayed: Subclass Mechanism of Action
- Sarcoma and Pnet
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- Regimen Reference Order – GYNE – Methotrexate + Dactinomycin
- Dactinomycin
- Adverse Mucocutaneous Reactions Related to Chemothera- Peutic Agents – Part II Reações Tegumentares Adversas Relacionadas Aos Agentes Antineoplásicos – Parte II
- Chemotherapy Diluent-Rate Guide
- (VBP) Chemotherapy in the Manag
- Do Not Tube List
- Gynaecomastia: Aetiology and Treatment Options
- BC Cancer Protocol Summary for Therapy for High Risk Gestational
- Bactericidal Effect of Combinations of Antimicrobial Drugs and Antineoplastic Antibiotics Against Staphylococcus Aureus JOHN Y
- Pharmacy Policy Statement
- Supplementary Online Content
- Hazardous Drug List
- Radiation Recall Phenomenon Associated with Arsenic Trioxide
- Sample Page 1
- Medications That Are Considered Hazardous
- PROPOSED LIST of CANCER MEDICINES Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines
- Dactinomycin: Drug Information
- Synergy Between Photodynamic Therapy and Dactinomycin Chemotherapy in 2D and 3D Ovarian Cancer Cell Cultures
- Antineoplastic Drugs